Tvardi Therapeutics, Inc. · NASDAQ:TVRD
Tvardi Therapeutics, Inc. shareholders
As of Jun 30, 2026, 56 institutions reported holding Tvardi Therapeutics, Inc., 16.7% of its shares. Largest: Slate Path Capital LP, Vanguard and American Financial Group Inc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Tvardi Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Slate Path Capital LP | 704K | 5.3% | no change | Aug 14, 2026 |
| Vanguard | 392K | 2.9% | −2,488 | Aug 13, 2026 |
| American Financial Group Inc | 224K | 1.7% | no change | Aug 12, 2026 |
| UBS | 111K | 0.83% | +60,679 | Aug 13, 2026 |
| Silvercrest Asset Management Group LLC | 101K | 0.76% | no change | Aug 14, 2026 |
| BlackRock | 95,478 | 0.72% | −293K | Aug 7, 2026 |
| Renaissance Technologies | 91,409 | 0.69% | −691 | Aug 13, 2026 |
| Geode Capital | 90,350 | 0.68% | −91,989 | Aug 12, 2026 |
| Morgan Stanley | 77,845 | 0.58% | +4,951 | Aug 13, 2026 |
| Duncan Williams Asset Management, LLC | 63,241 | 0.47% | no change | Jul 22, 2026 |